Abstract
Background: Neuroendocrine tumors, although relatively rare in incidence, are now the second most prevalent gastrointestinal neoplasm owing to indolent disease biology. A small but significant sub-group of neuroendocrine tumor patients suffer from diarrhea. This is usually secondary to carcinoid syndrome but can also be a result of short gut syndrome, bile acid excess or iatrogenic etiologies. Recently, an amino acid based oral rehydration solution (enterade® Advanced Oncology Formula) was found to have anti-diarrheal properties in preclinical models.
Methods: A retrospective chart review of all NET patients treated with enterade® AO was performed after IRB approval.
Results: Ninety-eight NET patients who had received enterade® AO at our clinic from May 2017 through June 2019 were included. Patients (N = 49 of 98) with follow up data on bowel movements (BMs) were included for final analysis. Eighty-four percent of patients (41/49) had fewer BMs after taking enterade® AO and 66% (27/41) reported more than 50% reduction in BM frequency. The mean number of daily BMs was 6.6 (range, 3–20) at baseline before initiation of therapy, while the mean number of BMs at 1 week time point post enterade® AO was 2.9 (range, 0–11).
Conclusions: Our retrospective observations are encouraging and support prospective validation with appropriate controls in NET patients. This is first published report of the potential anti-diarrheal activity of enterade® AO in NET patients.
Document Type
Article
Publication Date
5-20-2021
Digital Object Identifier (DOI)
https://doi.org/10.1186/s12885-021-08315-4
Related Content
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Repository Citation
Chauhan, Aman; Das, Satya; Miller, Rachel; Luque, Laura; Cheuvront, Samuel N.; Cloud, James; Tarter, Zach; Siddiqui, Fariha; Ramirez, Robert A.; and Anthony, Lowell B., "Can an Amino Acid Mixture Alleviate Gastrointestinal Symptoms in Neuroendocrine Tumor Patients?" (2021). Internal Medicine Faculty Publications. 247.
https://uknowledge.uky.edu/internalmedicine_facpub/247
Notes/Citation Information
Published in BMC Cancer, v. 21, issue 1, article no. 580.
© The Author(s) 2021
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.